Jeffrey A Munsie Net Worth & Insider Trades
Jeffrey A Munsie - Chief Legal Officer, Concert Pharmaceuticals, Inc
What is Jeffrey A Munsie's Net Worth?
The current estimated net worth of Concert Pharmaceuticals, Inc's Chief Legal Officer, Jeffrey A Munsie, is estimated to be about $407.86K . Jeffrey A Munsie owns about 88,049 units of Concert Pharmaceuticals, Inc common stock. In the last 4 years at Concert Pharmaceuticals, Inc, Jeffrey A Munsie has sold an estimated value of $171.7K worth.
What is Jeffrey A Munsie's Past Insider Trading?
Jeffrey A Munsie's largest sale order was 8,493 units , worth over $70.92K on January 31, 2023. In total, Jeffrey A Munsie has made about 11 transactions over 4 years of their time at Concert Pharmaceuticals, Inc. Jeffrey A Munsie usually trades in February, with the busiest year in 2023. The most recent transaction was a sale order of 3,762 units , worth over $31.38K on February 16, 2023.
Jeffrey A Munsie
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Jeffrey A Munsie's' Mailing Address?
- Mailing address is Concert Pharmaceuticals, Inc. 65 Hayden Avenue, Suite 3000n Lexington MA 02421 MA
Concert Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Roger D. Tung | 2020 | $581,967 | - | $1,011,657 | $1,098,957 | $320,082 | $12,114 | $3,024,777 |
| Roger D. Tung | 2019 | $562,287 | - | $1,889,500 | - | $309,258 | $11,304 | $2,772,349 |
| James V. Cassella | 2020 | $450,633 | - | $283,144 | $306,708 | $225,317 | $15,408 | $1,281,210 |
| James V. Cassella | 2019 | $435,394 | - | $708,563 | $319,397 | $217,697 | $13,988 | $1,695,039 |
| Nancy Stuart | 2020 | $444,530 | - | $455,212 | $493,096 | $177,812 | $12,114 | $1,582,764 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1367920/000136792021000022/a2021proxy.htm
What are Concert Pharmaceuticals, Inc's Past Insider Trades?
Concert Pharmaceuticals, Inc's most recent insider trade came on February 16, 2023 by Nancy Stuart who sold 6,048 units worth $50.38K . In the last 9 years, insiders at Concert Pharmaceuticals, Inc have sold an estimated value of $72.41M and bought an estimated value of $26.82M worth of shares. Insider trading is most common in June, with the busiest year in 2018 and 2015. The most active traders at the company are Nancy Stuart, Chief Operating Officer, Roger Tung, Chief Executive Officer, and James Cassella V, Chief Development Officer .
CONCERT PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||